![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif)
fluorine F 18 FEQA The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to (EGFR), allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif)
Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) | F-18 FEQA | | ![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) | Chemical structure name: | ![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) | N-{4-[(3'- [F-18] fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide | | ![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081025090117im_/http://www.cancer.gov/images/spacer.gif) |